Dylan Scott
Senior Correspondent
Latest articles by Dylan Scott
Alzheimer’s patients and families live in a cloud of uncertainty. It’s about to get worse.
Vox explores the successes — and setbacks — in six nations as they fought Covid-19.
The most promising frontier in US health policy has nothing to do with doctors or hospitals.
US health care is even further behind other wealthy nations.
Experts say it’s the wrong approach to curb costs.
Seniors want to age at home. But the US makes it hard.
The FDA’s controversial approval of a Biogen drug for Alzheimer’s disease could blunt future R&D, experts warn.
The Affordable Care Act is now a durable part of the American social safety net. Its successes and flaws have never been more apparent.
We’re about to learn a lot about how a public health insurance option actually works in the US.
Patients are desperate for hope. But there are serious concerns about Biogen’s new $56,000 treatment.